CONCILIUS AG
Budget
Not declared
EP Access
1
accredited persons
Staff
5
4 FTE
EU Grants
None
Mission & Goals
CONCILIUS advises companies, associations and other social actors at the interfaces with politics and administration in Germany and with the institutions of the European Union. With offices not only in Berlin and Brussels, but also in Munich, Stuttgart, Dusseldorf and Hamburg, we are able to address the special requirements of the federal political system in the best possible way. In addition to our services at EU, federal and state level, our clients value our expertise in supporting projects at the municipal level. Our consultants have excellent references and decades of experience in successfully dealing with regulatory issues in almost every industry sector. We emphasise a comprehensible, analysis-based and content- and target-oriented approach. CONCILIUS was founded in 2003 and is still managed by its owners.
EU Legislative Interests
AI Liability Directive; Alternative Fuels Infrastructure Regulation (AFIR); Alternative and Online Dispute Resolution Directive and Regulation; Anti-Money Laundering Regulation (AMLR); Artificial Intelligence Act; Aspects of Clean Industrial Deal relevant to pharmaceutical industry; Batteres and waste batteries; Beating Cancer Plan; Biotech Act; Circular Economy Action Plan; Clean Industria Deal; Clean Tech Act; Clinical trials regulation; Construction Product Regulation; Construction Products Regulation; Consumer Protection Cooperation Regulation (CPC); CO2 emission standards for trucks regulation; Corporate Sustainability Due Diligence Directive; Corporate Sustainability Reporting Directive (CSRD); CountEmissionsEU initiative; Cross Border Healthcare; Cross border Healthcare directive; Critical Medicines Act; Cyber Resilience Act; Cyber Solidarity Act; Cybersecurity; Cybersecurity (incl EUCS); Data Act; Detergents Regulation; Digital Euro; Digital Package; Digital Product Passport; Digital Services Act (DSA); Directive amending the Renewable Energy, Energy Performance of Buildings and Energy Efficiency Directives (REPowerEU - Permitting); Directive on Platform Work; eIDAS (Electronic Identification, Authentication and Trust Services); EMA Fees regulation; Empowering Consumers for the Green Transition (ECGT) Directive; Empowering consumers for the green transition; Establishing a European Bank for Hydrogen; Establishing the Single Market Emergency Instrument (SMEI); EU Beating Cancer Plan; EU Customs Reform initiative; EU Green Deal; EU HTA regulation; EU Hydrogen Strategy; EU Pharma Regulation (Revision); EU Space Act; EU Taxonomy; EU US relations; EU policies for SMEs; EU space strategy for security and defence; EcoDesign Directive; Ecodesign for Sustainable Products; Ecodesign for Sustainable Products Regulation; European Chips Act; European Critical Raw Materials Act; European Digital Identity (eID Regulation); European Green Deal; European Health Data Space (EHDS); European Health Data Space, and its interplay with other digital legislation such as GDPR and Data Act; European Standardization Strategy; European Strategy for Data; Fair Share/ Network Tax policy; Forced Labour Regulation; General Product Safety Regulation (GPSR); Gigabit Infrastructure Act; Green Claims Directive; Health Emergency Preparedness and Response Authority (HERA); Industrial Decarbonisation Accelerator Act; Industrial Emissions Directive (IED); Industrial Strategy, Important Projects of Common European Interest (IPCEI) on health; Instant Payments Regulation; Intellectual Property Enforcement Directive (IPRED); Intellectual Property Rights and Incentives; Interoperable Europe Act; International Health Regulations; International Trade, especially EU-US trade; Life Sciences Strategy; Malamud Case; Market Surveillance Regulation (Goods Package); Medical Device Regulation/In Vitro Devices Regulation; Multifinancial Framework Proposal (post 2027); Net Zero Industry Act; New Legislative Framework; Non-communicable diseases, especially Diabetes, Alzheimer’s and Obesity; Omnibus Package; Omnibus legislation relevant to pharmaceutical industry; Online fairness/dark patterns/withdrawals; Packaging and Packaging Waste Regulation (PPWR); Patent Package – SPC/uSPC for medicinal products, compulsory licensing; Payment Service Directive (Revision); PFAS; Pharmaceutical Strategy; Product Liability Directive (PLD); Proposal for a revision of EU legislation on Packaging and Packaging Waste (PPWR); Registration, Evaluation, Authorization and Restriction of Chemicals (REACH); Regulation on Child Sexual Abuse Material (CSAM); Regulation on Horizontal Cybersecurity Requirements for Products with Digital Elements (CRA); Regulation on Standards Essential Patents (SEPs); Regulation on the Certification of Carbon Removals; Regulation on classification, labelling, and packaging of chemicals (CLP); Regulation on the safety and quality of substances of human origin (SoHO)(...)
Communication Activities
Conference, virtual events, virtual and non-virtual meetings, report on annual activities
Interests Represented
Advances interests of their clients
Member Of
American Chamber of Commerce in Germany e.V. de'ge'pol - Deutsche Gesellschaft für Politikberatung e.V. Deutsche Gesellschaft für Auswärtige Politik e. V. DEUTSCHE GESELLSCHAFT FÜR WEHRTECHNIK e. V. (DWT) Förderkreis Deutsches Heer e.V. Forum Luft- und Raumfahrt e.V. Wirtschaftsforum der SPD e.V. Wirtschaftsbeirat Bayern - Wirtschaftsbeirat der Union e.V. Wirtschaftsrat der CDU e. V.
Organisation Members
AiDUO srl. - https://transparency-register.europa.eu/searchregister-or-update/organisation-detail_de?id=480053720211-20
Commissioner Meetings
No recorded meetings with EU commissioners.